3rd Quarter - Report

BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.

Firm
Client
Income
—
Expenses
$270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

GENERAL DISCUSSIONS REGARDING ORPHAN DRUG EXCLUSIVITY

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —
KATHRYN LOWELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

H.R.1262: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION S.932: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION GENERAL DISCUSSIONS REGARDING GENETIC SREENING AND NEWBORN SREENING GENERAL DISCUSSIONS REGARDING ORPHAN DRUGS GENERAL DISCUSSIONS RELATED TO MOST-FAVORED-NATION (MFN) DRUG PRICING GENERAL DISCUSSIONS RELATED TO THE PRIORITY REVIEW VOUCHER PROGRAM

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —
KATHRYN LOWELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 932 (119th), H.R. 1262 (119th)

Medicare/Medicaid MMM

H.R.1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S.752: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S.1637: MVP ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING MEDICAID DRUG REBATE PROGRAM GENERAL DISCUSSIONS REGARDING FOREIGN DRUG REFERENCE PRICING

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 752 (119th), H.R. 1509 (119th), S. 1637 (119th)

Tariff (miscellaneous tariff bills) TAR

GENERAL DISCUSSIONS REGARDING TARIFFS ON PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —
KATHRYN LOWELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Taxation/Internal Revenue Code TAX

GENERAL DISCUSSIONS REGARDING ORPHAN DRUG TAX CREDIT

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.